Tech Company Financing Transactions

Ambit Biosciences Funding Round

On 11/14/2007, Ambit Biosciences received $49.3 million in Series D funding from Applied Ventures, Avalon Ventures and Forward Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
The Series D funds will be used to support continued advancement of Ambit's growing product pipeline, which includes several drug candidates in clinical and pre-clinical development.

Company Information

Company Status
Acquired or Merged
Mailing Address
11080 Roselle St.
San Diego, CA 92121
Email Address
Ambit Biosciences is a biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.
Ambit Biosciences LinkedIn Company Profile
Social Media
Ambit Biosciences Company Twitter Account
Company News
Ambit Biosciences News
Ambit Biosciences on Facebook
Ambit Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Martino
  Michael Martino LinkedIn Profile  Michael Martino Twitter Account  Michael Martino News  Michael Martino on Facebook
Chief Financial Officer
Alan Fuhrman
  Alan Fuhrman LinkedIn Profile  Alan Fuhrman Twitter Account  Alan Fuhrman News  Alan Fuhrman on Facebook
Chief Medical Officer
Athena Countouriotis
  Athena Countouriotis LinkedIn Profile  Athena Countouriotis Twitter Account  Athena Countouriotis News  Athena Countouriotis on Facebook



Browse more venture capital transactions:

Prev: 11/14/2007: Silicon Clocks venture capital transaction
Next: 11/14/2007: OpenPages venture capital transaction


Share this article


About Our VC Transactions Data

Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary